Another Patent Setback for Myriad Genetics

, Corporate Counsel

   | 0 Comments

Myriad Genetics Inc. failed to convince a federal court to block a competitor from selling its own genetic tests while another patent-infringement case is pending.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202646469127

Thank you!

This article's comments will be reviewed.